EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction

Gabriela Rybka, Radosław Dziedzic, Kazimierz Węglarczyk, Mamert Milewski, Andżelika Siwiec-Koźlik, Sylwia Dziedzina, Marek Sanak, Jacek Musiał, Maciej Siedlar, Mariusz Korkosz, Joanna Kosałka-Węgiel

Clinical Rheumatology · 2026

DOI: 10.1007/s10067-025-07779-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, 2026. Verfasst von Gabriela Rybka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Kraków, Jakubowskiego 2, 30-688, Kraków, Poland. Hauptthemen laut MEDLINE: B-Cell Activating Factor, Lupus Erythematosus, Systemic, Interleukin-10, Tumor Necrosis Factor Ligand Superfamily Member 13. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science Center in Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by dysregulated innate and adaptive immune responses. However, data on immunologic disturbances in SLE flares remains limited. Thus, we aimed to evaluate serum levels of selected cytokines involved in its pathogenesis such as APRIL (a proliferation-inducing ligand), BAFF (B cell activating factor), and interleukin(IL)-10 levels in SLE patients to identify potential biomarkers of disease activity. PATIENTS AND METHODS: We investigated 52 patients with SLE: 15 (28.8%) with disease exacerbation (SLE disease activity index [SLEDAI] ≥ 5 points) and 37 (71.2%) in remission (SLEDAI < 5 points), and 12 controls matched by sex and age. All patients met the 2019 EULAR/ACR SLE criteria. Serum levels of APRIL, BAFF, and IL-10 were determined in all participants with the Luminex Discovery Assay Human Premixed Multi-Analyte Kit. RESULTS: We observed no significant differences in the serum levels of BAFF, APRIL, and IL-10 between active and inactive SLE patients or between active/inactive SLE patients and healthy controls, but also considering all SLE cases and the control group. There were no differences in the cytokine levels between patients with renal flare and those without renal flare in the active SLE group, but also in the inactive SLE group regarding the presence of lupus nephritis. Correlation analysis revealed a positive association between APRIL and BAFF (rs = 0.66, p < 0.001), BAFF and IL-10 (rs = 0.45, p < 0.001), and between APRIL and IL-10 (rs = 0.36, p = 0.004). Furthermore, regarding clinics, BAFF levels showed a moderate positive correlation with disease duration (rs = 0.30, p = 0.034), whereas IL-10 levels correlated positively with the SLEDAI score (rs = 0.34, p = 0.013). We found that anti-dsDNA antibody levels were significantly associated with all analyzed cytokines, including APRIL (rs = 0.35, p = 0.007), BAFF (rs = 0.37, p = 0.004), and IL-10 (rs = 0.41, p = 0.002). In the follow-up analysis, during a median observation period of 5.5 years, 10 out of 37 enrolled inactive SLE patients developed a disease flare, but no cytokine differences in baseline levels were found between those with or without a flare in the follow-up period. CONCLUSIONS: In our study, higher BAFF levels were associated with longer disease duration, while elevated IL-10 levels correlated with the SLEDAI score. Such correlations were not observed considering APRIL. However, all cytokines were also linked to higher anti-dsDNA antibody titers. Nevertheless, no significant differences in serum levels of APRIL, BAFF, and IL-10 were observed between active and inactive SLE patients, but also controls, limiting their potential as biomarkers of disease activity, but also their ability to predict disease flares. Key Points • Serum APRIL, BAFF, and IL-10 levels were similar between active and inactive SLE patients or compared with healthy controls. • BAFF correlated positively with disease duration, and IL-10 with the SLEDAI score. • None of the cytokines predicted future disease flares during a median follow-up period of 5.5 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-Cell Activating FactorLupus Erythematosus, SystemicInterleukin-10Tumor Necrosis Factor Ligand Superfamily Member 13HumansFemaleMaleBiomarkersAdultMiddle AgedSeverity of Illness IndexCase-Control StudiesSymptom Flare UpYoung Adult

Stichwörter der Autor:innen

APRILBAFFBiomarkersInterleukin-10Systemic lupus erythematosus

Substanzen

B-Cell Activating FactorInterleukin-10BiomarkersTumor Necrosis Factor Ligand Superfamily Member 13TNFSF13B protein, humanTNFSF13 protein, humanIL10 protein, human

Autor:innen und Institutionen

  • Clinical Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Kraków, Jakubowskiego 2, 30-688, Kraków, Poland.
  • Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, św. Łazarza 16, 31-530, Kraków, Poland.
  • Department of Clinical Immunology, Jagiellonian University Medical College, Wielicka 265, 30-663, Kraków, Poland.
  • Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College, Jakubowskiego 2, 30-688, Kraków, Poland.
  • Department of Rheumatology and Immunology, Jagiellonian University Medical College, Jakubowskiego 2, 30-688, Kraków, Poland.
  • Clinical Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Kraków, Jakubowskiego 2, 30-688, Kraków, Poland. joanna.kosalka@uj.edu.pl.

Förderung

  • National Science Center in Poland

Zitieren

APA

Rybka, G., Dziedzic, R., Węglarczyk, K., Milewski, M., Siwiec-Koźlik, A., Dziedzina, S., Sanak, M., Musiał, J., Siedlar, M., Korkosz, M., & Kosałka-Węgiel, J. (2026). Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07779-0

Vancouver

Rybka G, Dziedzic R, Węglarczyk K, Milewski M, Siwiec-Koźlik A, Dziedzina S, et al. Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction. Clinical Rheumatology. 2026. doi:10.1007/s10067-025-07779-0

BibTeX
@article{Rybka2026,
  author = {Rybka, Gabriela and Dziedzic, Radosław and Węglarczyk, Kazimierz and Milewski, Mamert and Siwiec-Koźlik, Andżelika and Dziedzina, Sylwia and Sanak, Marek and Musiał, Jacek and Siedlar, Maciej and Korkosz, Mariusz and Kosałka-Węgiel, Joanna},
  title = {Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction},
  journal = {Clinical Rheumatology},
  year = {2026},
  doi = {10.1007/s10067-025-07779-0}
}
Kostenlos starten →